NCT05800639 Frontal Alpha Asymmetry and Pediatric Emergence Delirium
| NCT ID | NCT05800639 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gangnam Severance Hospital |
| Condition | Emergence Delirium |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-04-06 |
| Primary Completion | 2026-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2023-04-06 with a primary completion date of 2026-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aimed to investigate whether the association between the preoperative anxiety level and emergence delirium involves EEG frontal alpha asymmetry in pediatric patients undergoing ophthalmic surgery under general anesthesia. The investigators hypothesized that EEG frontal alpha asymmetry contributes a significant portion of the preoperative anxiety - emergence delirium association in pediatric patients. Mediation analysis will be performed to estimate the relationships between preoperative anxiety of children (modified Yale Preoperative Anxiety Scale (mYPAS)), EEG frontal alpha asymmetry, and emergence delirium (Pediatric Assessment of Emergence Delirium (PAED) scale).
Eligibility Criteria
Inclusion Criteria: * Children aged 2-8 year * Children with an American Society of Anesthesiologists (ASA) physical status of I-II * Children who are scheduled to undergo elective ophthalmological requiring general anesthesia Exclusion Criteria: * Emergency surgery * Patients with developmental delays * Patients with neurological or psychiatric diseases associated with symptoms of agitation, anxiety, attention deficit, sleep disturbances * Patients with autism * Patients with a recent history (within one month) of receiving general anesthesia * Patients with congenital or genetic diseases that may influence brain development
Contact & Investigator
Young Song
PRINCIPAL INVESTIGATOR
Gangnam Severance Hospital
Frequently Asked Questions
Who can join the NCT05800639 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 8 Years, studying Emergence Delirium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05800639 currently recruiting?
Yes, NCT05800639 is actively recruiting participants. Contact the research team at mayskpark@gmail.com for enrollment information.
Where is the NCT05800639 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT05800639 clinical trial?
NCT05800639 is sponsored by Gangnam Severance Hospital. The principal investigator is Young Song at Gangnam Severance Hospital. The trial plans to enroll 80 participants.